Goodpasture disease: Difference between revisions
| Line 30: | Line 30: | ||
{{SK}} Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome | {{SK}} Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome | ||
== Treatment == | == Treatment == | ||
Revision as of 18:34, 24 September 2012
| Goodpasture disease | |
| ICD-10 | M31.0 (ILDS M31.010) |
|---|---|
| ICD-9 | 446.21 |
| OMIM | 233450 |
| DiseasesDB | 5363 |
| MedlinePlus | 142 |
| MeSH | D019867 |
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture disease On the Web |
|
American Roentgen Ray Society Images of Goodpasture disease |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome
Treatment
Like many autoimmune diseases, Goodpasture’s syndrome responds well to treatment with corticosteroids and immunosuppressants. These drugs dampen the body's normal immune response. A serious side effect of this is that the patient may become more susceptible to infections. The concentration of anti-GBM antibodies in the blood may be reduced by apheresis to remove blood plasma and its replacement with an isotonic salt and protein solution. This course of treatment usually lasts between three and six months.
Antibiotic treatment of lung infection and stopping smoking may also help to reduce lung haemorrhaging.
However, none of these can reverse permanent kidney damage and so for patients who have suffered this, renal transplant once the disease has subsided may be the only option.
See also
References
External links
GBM antibodies: immunofluorescence image
Template:Diseases of the musculoskeletal system and connective tissue